ID   INER-51
AC   CVCL_5531
SY   Instituto Nacional de Enfermedades Respiratorias-51
DR   BTO; BTO_0002559
DR   Wikidata; Q54897733
RX   PubMed=16001980;
RX   PubMed=16271071;
RX   PubMed=26221079;
CC   Doubling time: 51 hours (PubMed=26221079).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
RX   PubMed=16001980; DOI=10.1186/1475-2867-5-20; PMCID=PMC1185553;
RA   Ponce de Leon V., Barrera-Rodriguez R.;
RT   "Changes in P-glycoprotein activity are mediated by the growth of a
RT   tumour cell line as multicellular spheroids.";
RL   Cancer Cell Int. 5:20.1-20.13(2005).
//
RX   PubMed=16271071; DOI=10.1111/j.1349-7006.2005.00111.x; PMCID=PMC11158927;
RA   de Lucio B., Manuel V., Barrera-Rodriguez R.;
RT   "Characterization of human NSCLC cell line with innate
RT   etoposide-resistance mediated by cytoplasmic localization of
RT   topoisomerase II alpha.";
RL   Cancer Sci. 96:774-783(2005).
//
RX   PubMed=26221079; DOI=10.1186/s12935-015-0200-6; PMCID=PMC4517505;
RA   Barrera-Rodriguez R., Fuentes J.M.;
RT   "Multidrug resistance characterization in multicellular tumour
RT   spheroids from two human lung cancer cell lines.";
RL   Cancer Cell Int. 15:47.1-47.11(2015).
//